Methods for evaluation of medication adherence and persistence using automated databases

Pharmacoepidemiology and Drug Safety

Volumn 15, Issue 8, 2006, Pages 565-574

  Andrade, Susan E ^a   Kahler, Kristijan H ^b   Frech, Feride ^b   Chan, K Arnold ^c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adherence; Administrative data; Automated data; Medication compliance; Persistence

Indexed keywords

ANALYTIC METHOD; AUTOMATION; DATA BASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; INFORMATION PROCESSING; MEDICAL LITERATURE; MEDICAL RECORD; MEDLINE; PATIENT COMPLIANCE; PHARMACOECONOMICS; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; PUBLICATION; REVIEW; SYSTEMATIC REVIEW;

DATABASES, FACTUAL; DRUG PRESCRIPTIONS; DRUG THERAPY; HUMANS; PATIENT COMPLIANCE; PHARMACIES; PHARMACOEPIDEMIOLOGY; PRESCRIPTIONS, DRUG;

EID: 33748343357     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1230     Document Type: Review

References (22)

1. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 2001; 26(5): 331-342.
2. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004; 27(5): 1218-1224.
3. Gerth WC. Compliance and persistence with newer antihypertensive agents. Curr Hypertens Rep 2002; 4(6): 424-433.
4. Payne KA, Esmonde-White S. Observational studies of antihypertensive medication use and compliance: is drug choice a factor in treatment adherence? Curr Hypertens Rep 2000; 2(6): 515-524.
5. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997; 50(1): 105-116.
6. Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother 2004; 38(2): 303-312.
7. Bender B, Milgrom H, Rand C. Nonadherence in asthmatic patients: is there a solution to the problem? Ann Allergy Asthma Immunol 1997; 79(3): 177-185.
8. Caro JJ, Speckman JL. Existing treatment strategies: does noncompliance make a difference? J Hypertens Suppl 1998; 16(7): S31-S34.
9. Dezii CM. Persistence with drug therapy: a practical approach using administrative claims data. Manag Care 2001; 10(2): 42-45.
10. Nichol MB, Venturini F, Sung JC. A critical evaluation of the methodology of the literature on medication compliance. Ann Pharmacother 1999; 33(5): 531-540.
11. ISPOR Medication Compliance Special Interest Group. Available at: http:// www.ispor.org/sigs/medication.asp [Accessed 23 June 2005].
12. Degli Esposti E, Sturani A, Degli Esposti L, et al. Pharmacoutilization of antihypertensive drugs: a model of analysis. Int J Clin Pharmacol Ther 2001; 39(6): 251-258.
13. Chan KW, Walker AM, Yood RA. An equilibrium model of drug utilization. J Clin Epidemiol 1993; 46(1): 113-121.
14. Walker AM, Chan KW, Yood RA. Patterns of interchange in the dispensing of non-steroidal anti-inflammatory drugs. J Clin Epidemiol 1992; 45(2): 187-195.
15. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000; 160(21): 3278-3285.
16. Bailey JE, Lee MD, Somes GW, Graham RL. Risk factors for antihypertensive medication refill failure by patients under Medicaid managed care. Clin Ther 1996; 18(6): 1252-1262.
17. Bukstein DA, Henk HJ, Luskin AT. A comparison of asthma-related expenditures for patients started on montelukast versus fluticasone propionate as monotherapy. Clin Ther 2001; 23(9): 1589-1600.
18. Bukstein DA, Luskin AT, Bernstein A. Real-world" effectiveness of daily controller medicine in children with mild persistent asthma. Ann Allergy Asthma Immunol 2003; 90(5): 543-549.
19. Stoloff SW, Stempel DA, Meyer J, Stanford RH, Carranza Rosenzweig JR. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. J Allergy Clin Immunol 2004; 113(2): 245-251.
20. Rahimtoola H, Buurma H, Tijssen CC, Leufkens HG, Egberts AC. Migraine prophylactic medication usage patterns in The Netherlands. Cephalalgia 2003; 23(4): 293-301.
21. Caro JJ, Speckman JL, Salas M, Raggio G, Jackson JD. Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. CMAJ 1999; 160(1): 41-46.
22. Urquhart J. Defining the margins for errors in patient compliance with prescribed drug regimens. Pharmacoepidemiol Drug Saf 2000; 9: 565-568.